Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.75

+0.1%

Jan 12 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Webhead who wrote (3922)	7/8/1997 5:43:00 PM
From: Henry Niman	of 32384

ECG, I too found the positive results on oral Panretin promising. LGND is able to begin trials on a number of indications by treating a small patient population. They then select the most promising for further development. As noted in the press release, patients with several tumor types have responded to treatment. Some have shown disease stabilization, but trials have not been advanced because of limited resources. Other diseases, such as non-small cell lung cancer (for Targretin) are moving forward with disease stabilization as one of the end points because of the poor outlook for the patients when treated with other drugs, including toxic chemotherapies which sometimes generate fatal side effects, including destruction of the immune system (patients die of a raging infection instead of their cancer). Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next